Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ondas Inc. Common Stock (ONDS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Ondas Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Ondas Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Ondas Inc. Common Stock trades at $6.03 (market cap $3.90B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Ondas Inc. Common Stock is far larger — about 2.2× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ondas Inc. Common Stock for 2 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

ONDSVIR
Market Cap
$3.90B$1.80B
Volume
70,281,0191,782,836
Sector
TechnologyHealth
52-Week High
$14.01$11.78
52-Week Low
$5.25$5.12
Typical Hold Time
2 Days0 Days
Enterprise Value
$2.53B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ondas Inc. Common Stock

ONDS trades at $6.71, up 0.6% on the day, amid mixed technical signals with a bearish moving average trend but oversold RSI levels. The company reported a net loss of $132.02M for 2025 but shows a projected turnaround to $168M net profit for 2026. Recent developments include a strategic AI venture with Palantir and over $270M in new defense orders, boosting revenue visibility. Analyst sentiment is unanimously bullish with a consensus price target of $18.50.

The outlook for ONDS hinges on executing its growth strategy and achieving profitability targets. Investment opportunity lies in its expanding defense contracts and AI initiatives, but risks include persistent cash burn, high valuation multiples, and sector volatility. The stock presents a high-risk, high-reward profile dependent on successful operational execution and market adoption of its autonomous defense technologies.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ONDS
100% Buy0% Sell
Avg holding period · 2 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Ondas Inc. Common Stock

Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.

Read more on ONDS →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →